App-Quantinova.ai

Genotype-Guided Vitamin K Antagonist Dosing Algorithms Improve Time in Therapeutic Range: A Systematic Review and Meta-Analysis

Hasib Hanif - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Venous Thromboembolism Recurrence Rate and Risk Factors in a European Population

Amir Goren - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Long-Term Clinical Outcomes of Everolimus-Eluting Stents versus Sirolimus-Eluting Stents: Systematic Review and a Meta-Analysis of 14 Randomized Control Trials, Focused on Stent Thrombosis

Hiroki Shiomi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Impact of Post Dilatation on the One-Year Clinical Outcomes of a Large Cohort of Patients Treated Solely With the Absorb Bioresorbable Vascular Scaffold

Alexandre Abizaid - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Association of Out-of-Range International Normalized Ratio (INR) Values and Adverse Clinical Outcomes Among Newly Initiated Warfarin Patients With Non-Valvular Atrial Fibrillation and Comorbid Diabetes

Li Wang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Three Year Clinical and Imaging Data of the Paclitaxel-Eluting Absorbable Magnesium Scaffold (Dreams) From the Biosolve-I Study

Stadtische Kliniken-Neuss - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroglycerin

Side Branch Angle Influences the Neointimal Coverage of Drug-Eluting Stent in Coronary Bifurcation Lesions: An Optical Coherence Tomography Study

Shiro Uemura - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Features, Prognosis and Risk Stratification of Acute Myocardial Infarction Due to Coronary Embolism

Teruo Noguchi - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Persistent No Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Was Associated With a Poor In-Hospital Outcome and Increased Long-Term Mortality, Mainly Driven by Increased Cardiac Mortality

Hae Chang Jeong - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Rapid Atrial Pacing Augments Fibrinogen Expression With Activation of IL-6/STAT3 Signaling Pathway in the Rat Liver

Takeshi Kato - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Thrombate III

Safety and Efficacy of Everolimus-Eluting Stent versus Zotarolimus-Eluting Stent: A Meta-Analysis of Randomized Controlled Clinical Trials and Observational Studies

Kun Hua - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Placement of Proximal Edge on TCFA and Calcification Correlates With Inadequate Neointimal Coverage of Struts After Drug Eluting Stent Implantation

Shiro Uemura - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Coronary Stent Fracture Promotes Neoatherosclerosis Formation in-Stent Restenotic Neointimal Tissue After Drug-Eluting Stent Implantation

Satoshi Ichimiya - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Left Atrial Appendage CT Contrast Defects Correlate With CHADS2 Score and is a Prognostic Indicator for Embolism in Subjects With Atrial Fibrillation or Flutter

Hiroyuki Takaoka - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Efficacy of Cilostazol on Platelet Reactivity and Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention: Insights From a Meta-Analysis of Randomized Trials

Amita Singh - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation for Off-Label vs. On-Label Indications

Jung-Min Ahn - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

Efficacy and Safety of an Anticoagulation Clinic in Low-income Brazilian Patients With Heart Disease: a Randomized Clinical Trial

Joao A Q Oliveira - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Incidence of Stent Complications detected by Optical Coherence Tomography and their Clinical Significance: One Year Follow up Study

Seung-Jung Park - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Patterns of OCT Detected Stent Complications are Different between Acute Myocardial Infarction and Stable Angina

Yangsoo Jang - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Nitrogen Rich Plasma Activated Coatings for Enhancement of Endovascular Stent Biocompatibility

Alexey Kondyurin - American Heart Association (AHA) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts